A Significant Increase in the Incidence of Central Precocious Puberty among Korean Girls from 2004 to 2010

Shin Hye Kim1, Kyoung Huh2, Sungho Won3

  • 1Department of Pediatrics, Sanggye Paik Hospital, Inje University, College of Medicine, Seoul, Korea.

Plos One
|November 6, 2015
PubMed

Insights

The annual incidence of central precocious puberty (CPP) significantly increased in Korean girls from 2004-2010, while boys showed a smaller rise. Continued monitoring of CPP trends in children is recommended.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Surveillance
  • Growth and Development Disorders

Background:

  • Limited data exists on central precocious puberty (CPP) trends in Asian populations.
  • This study addresses the knowledge gap by examining CPP prevalence and incidence in Korean children.

Purpose of the Study:

  • To assess the prevalence and annual incidence of central precocious puberty (CPP) in Korean children.
  • To analyze trends in CPP incidence based on age and gender over a defined period.

Main Methods:

  • Utilized data from the Korean Health Insurance Review Agency (2004-2010).
  • Reviewed records of 21,351 children diagnosed with CPP or treated with gonadotropin-releasing hormone analogs.

Main Results:

  • CPP prevalence: 55.9/100,000 girls, 1.7/100,000 boys.
  • Annual incidence in girls rose from 3.3 to 50.4/100,000; boys increased from 0.3 to 1.2/100,000.
  • Incidence increased with age in girls (especially ≥6 years) and showed minimal change in boys <8 years.

Conclusions:

  • A substantial increase in the annual incidence of CPP was observed in Korean girls over seven years.
  • Significant age and gender differences were noted in CPP incidence trends.
  • Ongoing surveillance of CPP trends in Korean children is crucial.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
462
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

3.8K